30 closest matches · ranked by relevance
Phobias
Primary: GSR Trial 1 — .62; .55; .55; .67 units on a scale
Hypothermia
Primary: Measurement of Core Temperature — 36.42; 36.44; 35.96; 36.35 degree C
Hypotension · Anesthesia
Primary: Number of Participants Who Had Hypotensive Events — 8; 21 Participants — p=0.01
Hypertension
Primary: Median Dose Required to Increase the Systolic Blood Pressure (SBP) — 35; 43; 45 ng/kg/min
Inflammatory Lung Injury · Ischemia-Reperfusion Lung Injury · Postoperative Pulmonary Complications
Primary: Bronchoalveolar Lavage (BAL) Concentration of TNF Alpha (pg/mL) — 0.53; 0.53; 22.06; 102.04 pg/mL
Lumbar Spondylosis · Cervical Spondylosis · Hip Osteoarthritis
Primary: Change in Neurocognitive Performance (Z-score) — .09; -.20; -.42; .01 z score
Anesthesia
Primary: Lymphocyte Count — 0.55; 0.73; 0.73 cells/nanoliter
Anesthesia
Primary: Frequencies At Which Changes in Alpha, Theta, and Slow-Delta Wave Power Were Observed From Baseline During Sevoflurane-induced General Anesthesia — 10; 5; 1 Hz
Acute Respiratory Failure
Primary: All-cause, 28-day, In-hospital Mortality — 330; 345 Participants
Shoulder Pain
Primary: Number of Participants That Need an Airway Intervention. — 0; 5 participants
Anesthesia, General
Primary: Time to Loss of Consciousness of Patients Administered Anesthesia — 2.7 Minutes
Postoperative Pain
Primary: EC50 for Successful Intubation in Each Groups — 3.00; 2.00; 1.29 vol%
Hypoventilation
Primary: Intraoperative Hypoventilation — 1.2; 65 % time
Coronary Artery Disease · General Anesthetic Drug Allergy · Coronary Artery Bypass Graft Surgery
Primary: Blood Level of Troponin I — 2.16; 2.57 ng/mL — p=0.02
Liver Dysfunction
Primary: Changes in the M30 and M65 Markers Related to the Anesthesia Type — 237.27; 279.97; 427.33; 470.30 U/L
Pregnancy Termination in Second Trimester
Primary: Visual Analog Scale (VAS) Score for Maximum Procedural Pain — 54.1; 34.0 units on a scale
Blood Loss · Anesthesia
Primary: Number of Participants Needing Intervention to Treat Blood Loss (a Composite of Use of Uterotonics, Re-aspiration, and Bimanual Massage) — 20; 13 Participants
Macular Degeneration
Primary: Discomfort Associated With the Intravitreal Injection — 3; 2.3; 2.8; 3.1 units on a scale — p=0.28
Advanced Chronic Rhinosinusitis
Primary: Intraoperative Visual Field Assessment — 3.3; 4.3; 3.3; 4.2 units on a scale
Emergence Delirium
Primary: Emergence Agitation — 3.9; 2.5 Score on a scale — p=0.001
Sedation
Primary: Percentage of Time of Adequately Maintained Sedation Depth up to 48 Hours (± 6 Hours) — 62.37; 68.94 Percentage of time
Phacoemulsification · Cataract
Primary: Eye Mobility During Surgery (See Link to Study Protocol for Scale) — 1.39; 1.41; 1.31 units on a scale
Anesthesia
Primary: Dose of Propofol Required to Prevent Movement (Response) to Insertion of Endoscope Into the Patient's Esophagus — 6.1; 4.5; 4.7; 1.1 mg/kg
Adult Intracranial Tumor · Adult Solid Tumor
Primary: Hemodynamics — 98; 88 mmHg — p=< 0.001
Postoperative Confusion
Primary: Mini Mental State Examination (MMSE) Score at the Second Hour After Surgery — 27.40; 26.45 scores on a scale
Anesthesia
Primary: Slope of EEG Theta Band Power Over Fentanyl Effect Site Concentration (dB/ng/mL) — 0.55 dB / nano gram / mL
Epilepsy
Primary: Patients Satisfaction — 6.33; 6.45 score on a scale
Anesthesia, General
Primary: Time to Loss of Consciousness of Patients Administered Anesthesia — 3.0 minutes
Emergence Agitation
Primary: Number of Participants With Emergent Agitation — 16; 24 Participants
Postoperative Nausea and Vomiting
Primary: PONV During the First 24 Hours After Bariatric Surgery — 22; 12 participants — p=0.04